IBR Inc.

IBR Inc., Institute for Biopharmaceutical Research is a research-driven provider of preclinical services with a core expertise in inflammatory diseases. The main operative activities focus on biologicals including therapeutic antibodies and vaccines. GLP compliant test facilities and a well trained team of scientists are behind the excellence of the contract research and biopharmaceutical services. Main services are preclinical R&D, lot release of biopharmaceuticals, stability trials acc. to the ICH guidelines, compound screening for immunotoxicology as well as biological and analytical assay development. In addition, IBR Inc. is engaged in the development of diagnostics in the field of alcohol abuse.